… Markers Initiative (PPMI) study expands recruitment to Canada to help speed cures and disease prevention Canadians recently diagnosed with Parkinson’s or aged 60 or older without Parkinson’s are … the full spectrum of disease and its need for everyone to become an active participant in being part of the solution. …

… Study Rationale: Because Parkinson's disease (PD) is a complex disease, it is difficult to accurately diagnose and treat. Biomarkers -- disease … reliable biomarkers based on methylation of DNA that varies with disease progression. Study Design: We will analyze …

… Study Rationale: Parkinson’s disease with mild cognitive impairment (PD-MCI) is common, has important clinical consequences, and there is … in models. And these drugs also had an effect on motor symptoms in PD. This study will test for the first time …

… Objective/Rationale: Much recent work has suggested that comprehending the biological properties of an enzyme termed … of Parkinson’s disease as well as designing new strategies to better treat this condition. Our objective is to deploy … molecular understanding of LRRK2 biology will provide us with a framework of knowledge that will lead to new ideas …

… Chris Tracey (back row, fourth from left) pictured with friends and members of the 'Race with Trace' marathon relay teams. This past fall, fifteen friends gathered together to participate on three separate teams in the Cape …

… Markers Initiative will include Verily Study Watch to add new dimension of health data  Data collected through … Research (MJFF) and Verily Life Sciences LLC, an Alphabet company, will outfit more than 800 participants in the … longitudinal Parkinson's Progression Markers Initiative with the Verily Study Watch, Verily's multi-sensor …